FRF-HHO: Early ovarian cancer prediction using explainable fuzzy random forest optimized by Harris Hawks algorithm

Read full text
Authors: K.M. Yeaser Arafat, Ahmed Hossain, Mushfika Ikfat, Md. Areful Amin, Kazi Tanvir, Dipta Justin Gomes, Mahfujur Rahman
Cited by: 1
References: 17

Abstract

Ovarian cancer remains one of the most lethal gynecological malignancies, largely due to delayed diagnosis and the absence of reliable early screening tools. This study proposes an interpretable machine learning framework that integrates Fuzzy Random Forest (FRF) with Harris Hawks Optimization (HHO) for early ovarian cancer prediction using routine clinical data. The analysis was conducted on a publicly available dataset comprising 349 patient records with 51 clinical and biochemical features. To mitigate overfitting and data leakage, Recursive Feature Elimination with Cross-Validation (RFECV), preprocessing, and SMOTE–Tomek balancing were applied exclusively within the training data. A total of 31 relevant biomarkers were selected for model development. The HHO-optimized FRF achieved an accuracy of 94.12%, precision of 91.43%, recall of 96.07%, and an F1-score of 93.69%, outperforming several baseline ensemble and gradient boosting models evaluated under identical experimental conditions. Model interpretability was enhanced through SHAP and LIME analyses, which consistently identified AFP, HE4, CA125, and Age as influential predictors, aligning with established clinical knowledge. The high recall indicates strong sensitivity to cancer cases, an essential requirement for diagnostic support. Despite encouraging performance, the study is limited by its moderate sample size and a retrospective design. Consequently, the findings should be interpreted as preliminary. Future work will focus on validation using larger, multi-center cohorts and prospective studies to assess generalizability and clinical scalability. • Hybrid FRF-HHO model achieved 94.12% accuracy and 96.07% recall for early ovarian cancer prediction. • RFECV selected 31 key clinical biomarkers, improving diagnostic precision and reducing dimensionality. • Explainable AI (SHAP and LIME) revealed AFP, HE4, CA125, and Age as dominant diagnostic indicators. • Model demonstrated superior interpretability and reliability, outperforming existing ML frameworks statistically (p < 0.05).

Fields of Study & Subjects

Ovarian cancer diagnosis and treatment AI in cancer detection Ovarian function and disorders

Publication details

Journal / source
Advances in Biomarker Sciences and Technology
Publisher
Elsevier BV
Volume
8
Pages
219–235
Publication date
1 January 2026
Language
EN